TB Alliance manages the largest pipeline of new TB drugs in history.
The Director, Market Access will be responsible for implementation of market interventions and will play a key role in increasing access to and adoption of new TB regimens in low- and middle-income countries especially those with high incidence of tuberculosis. Through market understanding and implementing access strategies, the Director, Market Access will contribute to broad access, availability, and rapid and successful introduction of improved TB treatments, working at both a global and country level.
The position is very broad in scope, with involvement in both market research and implementation of high impact initiatives, both with technical, global health collaborators and commercial partners. Market access at the TB Alliance includes all elements on the value chain including manufacturing, pricing, forecasting, procurement, and regulatory issues as well as technical adoption-related issues such as policy, market understanding, and diagnostics.
The opening is happening at an exciting time for new TB regimens. Regulatory approval for the novel, short, all-oral regimen for XDR-TB is expected in August 2019, and work is ongoing to support planning for a forthcoming short regimen for both DS and MDR-TB.
To apply for this position, send resumes and cover letters to firstname.lastname@example.org. Please include the position title in the subject line.
TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster, affordable tuberculosis drugs that are available to those who need them.Through innovative science and with partners around the globe, we lead a global effort to ensure development of and equitable access to faster, better tuberculosis cures that will advance global health and prosperity.
With an annual operating budget of approximately $60 million, the TB Alliance leads the advancement of the most comprehensive R&D portfolio of TB drug candidates in history. Additionally, the TB Alliance drives efforts to ensure regulatory approval, country adoption of new regimens, and widespread availability of new drug regimens to patients. For more information, please access the website: www.tballiance.org.